Intravascular Large B-Cell Lymphoma

specific

A rare extranodal B-cell non-Hodgkin lymphoma, characterized by the presence of lymphoma cells exclusively in the lumina of small vessels, particularly capillaries. This is an extremely aggressive lymphoma which responds poorly to chemotherapy. (WHO, 2001)

Centers

Active Trials

—

Cancer Funding

Top Centers for Intravascular Large B-Cell Lymphoma(36)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	64.5
2	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program	Active Research Program	1	—	64.5
3	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program	Active Research Program	1	—	64.5
4	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive Active Research Program	Active Research Program	1	—	64.5
5	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive Active Research Program	Active Research Program	1	—	64.5
6	Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	64.5
7	Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program	Active Research Program	1	—	64.5
8	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	64.5
9	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program	Active Research Program	1	—	64.5
10	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program	Active Research Program	1	—	64.5
11	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program	Active Research Program	1	—	64.5
12	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	1	—	64.5
13	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	1	—	64.5
14	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program	Active Research Program	1	—	64.5
15	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program	Active Research Program	1	—	64.5
16	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive		—	—	42.0
17	UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive		—	—	42.0
18	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive		—	—	42.0
19	Winship Cancer InstituteAtlanta, GA NCI Comprehensive		—	—	42.0
20	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive		—	—	42.0
21	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive		—	—	42.0
22	University of Colorado Cancer CenterAurora, CO NCI Comprehensive		—	—	42.0
23	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive		—	—	42.0
24	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive		—	—	42.0
25	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical		—	—	42.0
26	Cedars-Sinai CancerLos Angeles, CA		—	—	42.0
27	VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive		—	—	42.0
28	Cleveland Clinic Cancer CenterCleveland, OH		—	—	42.0
29	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical		—	—	42.0
30	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive		—	—	42.0
31	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical		—	—	42.0
32	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR		—	—	42.0
33	Boston University Cancer CenterBoston, MA		—	—	42.0
34	Georgia Cancer Center, Augusta UniversityAugusta, GA		—	—	42.0
35	Upstate Cancer CenterSyracuse, NY		—	—	42.0
36	Louisiana Cancer Research CenterNew Orleans, LA		—	—	42.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →